
Drug Therapy for Osteoporosis
Studies have shown that high levels of estrogen (a hormone) minimize the risk of osteoporosis for women. After menopause, however, a woman is at greater risk because of the decreased levels of estrogen. Hormone replacement therapy (HRT) can prolong the protection from osteoporosis and prevent heart disease. But for benefits, long-term use is required and there is an increased risk of breast cancer associated with long-term use. HRT is a personal decision that should be made in consultation with your physician.
Fosamax TM
Alendronate, or Fosamax, is the first nonhormonal bone-restoring
drug that has been marketed in the United States. Many trials have indicated
that FosamaxT can reduce spine and hip fractures in 50% of patients with
osteoporosis.
Fosamax should be taken once a day with a full glass of water and 30 minutes before you consume any food, beverage, or other medication. Waiting more than 30 minutes before eating can improve the absorption of the drug. After taking the drug, do not lie down for at least 30 minutes to promote delivery to the stomach to help avoid gastrointestinal (digestive) problems.
Fosamax is a prescription medication and can only be prescribed by your physician.
Nancy J. Chaffee, R.P.H, M.S.H.A.
Columbus, Georgia
![]()